For more information...
Pneumococcal Polysaccharide Vaccine - What you need to know.
PNEUMOCOCCAL POLYSACCHARIDE VACCINE: WHAT YOU NEED TO KNOW
The pneumococcal polysaccharide vaccine (PPV) protects against 23 types of pneumococcal bacteria. Most healthy adults who get the vaccine develop protection to most or all of these types within 2 to 3 weeks of getting the shot.Very old people, children under 2 years of age, and people with some long-term illnesses might not respond.
Pneumococcal Congugated Vaccine - What you need to know.
PNEUMOCOCCAL CONJUJATED VACCINE: WHAT YOU NEED TO KNOW
Infection with Streptococcus pneumoniae bacteria can cause serious illness and death. Invasive pneumococcal disease is responsible for about 200 deaths each year among children under 5 years old. It is the leading cause of bacterial meningitis in the United States.
Vaccine Information for the public and health professionals: Pneumococcal Vaccine
The first pneumococcal polysaccharide vaccine was licensed in the United States in 1977. In 1983, an improved pneumococcal polysaccharide vaccine was licensed, containing purified protein from 23 types of pneumococcal bacteria (the old formulation contained 14 types). This pneumococcal polysaccharide vaccine is commonly known as PPV23 or PPV. The PPV vaccine is licensed for use in adults and persons with certain risk factors who are over two years of age.